Loading article…
Pfizer stock down 1% to $25, trading at 9x forward earnings; dividend 6.8%; watch earnings and patent cliff news.
Pfizer (NYSE:PFE) fell 1% on the day, settling around $25 per share, as analysts highlighted the drugmaker’s modest earnings growth and looming patent expirations that keep investors cautious [1].
| At a glance | |
|---|---|
| Price | $25 |
| 24h Change | –1% |
| Forward P/E | 9× |
| Dividend Yield | 6.8% |
Pfizer’s modest 1% price dip reflects a broader market view that the company’s earnings are barely expanding—up roughly 1% year‑to‑date—while its stock remains down about 37% over the past five years [1]. The forward price‑to‑earnings multiple of nine suggests a sizable margin of safety compared with many peers, but the figure also signals limited growth expectations. Analysts point to the “patent cliff” on key drugs as a primary risk, even as Pfizer has tried to offset this by acquiring Metsera, which adds a GLP‑1 candidate (MET‑097i) to its pipeline [1]. The company’s revenue last year was $62.6 billion, a slight decline from the prior year, underscoring the need for new products to sustain momentum [1].
At a 9× forward earnings multiple, Pfizer trades at a deep discount to projected earnings, a level that some value investors find attractive. The stock also offers a 6.8% dividend yield, providing cash flow for income‑focused investors amid the earnings slowdown [1]. However, the dividend alone does not offset concerns about growth, as the market continues to price in the impact of upcoming drug expirations. The combination of a low forward P/E and a high dividend yield makes the stock a classic “value” play, but the upside is constrained by the uncertainty surrounding its pipeline and competitive pressures in the GLP‑1 space.
Pfizer’s current price reflects a balance between its attractive dividend and the risk of stagnant earnings, leaving investors to decide whether the deep discount justifies the patent‑cliff exposure.
Coverage is mostly measured — 124 of 135 reports stay neutral.
Every Monday — the token unlocks, Fed dates & catalysts set to move crypto and markets this week. So you’re never blindsided.
Free · 3-min read · one-click unsubscribe
AI-assisted synthesis by the TrendWatcher Editorial Desk · sourced from 2 outlets · Jun 18, 2026 · How we report
The Stock-to-Flow model is a valuation framework that estimates the price of Bitcoin based on its scarcity, defined as the ratio between the total existing supply and the new supply produced through mining. It treats Bitcoin as a store-of-value commodity similar to precious metals like gold.
The Stock-to-Flow model incorporates Bitcoin halving events, which occur every 210,000 blocks, to account for the reduction in new supply entering the market. Because the model assumes that increased scarcity leads to higher prices, it projects price increases following these scheduled reductions in mining rewards.
The Stock-to-Flow model is not considered a reliable standalone price prediction tool because Bitcoin's market price has frequently deviated from its projections in recent years. While it was influential in earlier market cycles, many investors now treat the Stock-to-Flow model as a historical reference rather than a precise forecasting tool.
The Stock-to-Flow model is associated with an anonymous individual known as Plan B, who communicates primarily via Twitter. The name refers to the concept of Bitcoin acting as an alternative to the existing government-controlled monetary system.